Brigit Biofarmaka Teknologi Tbk. vs Superkrane Mitra Utama Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume), while Superkrane Mitra Utama Tbk. trades at Rp412 (market cap 3.14T, 158K 24h volume). The key difference: Superkrane Mitra Utama Tbk. is far larger — about 18.9× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (324K versus 158K). Which is the better fit depends on your goals.
| OBAT | SKRN | |
|---|---|---|
Market Cap | 166.01B | 3.14T |
Volume | 324K | 158K |
Lot | 3.24K | 1.58K |
Turnover | 77.68M | 64.61M |
Average Price | 239.75 | 408.9 |
Value | 77.68M | 64.61M |
Indicative Equilibrium Price | 240 | 412 |
Indicative Equilibrium Volume | 1 | 122 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Superkrane Mitra Utama Tbk (the Company) was established based on Deed No. 285 by notary Ratna Komala Komar, S.H., dated March 27, 1996, in Jakarta.
Read more on SKRN →